Exelixis | Zysk Brutto



Pre Tax Profit Zmiana Data
Acadia Pharmaceuticals USD 40.21M 12.43M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
Amgen USD 1.57B 405M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Bayer EUR -426000000 2.26B 2025-06
BioMarin Pharmaceutical USD 297.87M 59.78M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Cytokinetics USD -134370000 27.01M 2025-06
Eisai JPY 22.4B 22.43B 2025-06
Eli Lilly USD 6.78B 3.32B 2025-06
Exelixis USD 230.42M 24.72M 2025-06
Genmab DKK 423M 179M 2025-06
Glaxosmithkline USD 1.89B 230.76M 2025-06
Incyte USD 558.01M 323.82M 2025-06
Ionis Pharmaceuticals USD 124M 271M 2025-06
MacroGenics USD -36150000 21.67M 2025-06
Merck USD 6.77B 864M 2025-06
Moderna USD -818000000 146M 2025-06
Neurocrine Biosciences USD 159.5M 144.8M 2025-06
Novartis USD 4.53B 124M 2025-06
Pfizer USD 3.04B 259M 2025-06
Sanofi USD 1.47B 855.43M 2025-06
Takeda JPY 150.63B 257.93B 2025-06
Ultragenyx Pharmaceutical USD -114004000 35.77M 2025-06
Xencor USD -31075000 17.19M 2025-06


Exelixis Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.